Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR: Best practices in global flow cytometry quality control and harmonization 2 days 15 hours 19 mins 5 secs REGISTER NOW

Echo® MS System for high-throughput analysis

2 Nov 2020
Written by SCIEX
Drug development MS (LC–MS/MS, HRMS, IMS)

This presentation outlines the analytical challenges in MS-based screening, acoustic ejection mass spectrometry technology and the application of the Echo® MS System beyond drug discovery and development.

 

SPOTLIGHT-Echo-MS press-release slides-Chang-min


This content was supplied by SCIEX. 

Top content

  • Gilead to buy Arcellx for up to $7.8 billion
  • Can we predict Alzheimer’s years in advance?
  • Advancing HIV research and equity: Dionna’s unique path in science

Related tags

LC-MS sciex
Previous article Next article

Related articles

3 OCT 2013 GENERAL INTEREST
Watch the AB SCIEX Pharma & Biologics Webinar Series from August 21-December 4, 2013
11 JAN 2012 DATA PROCESSING AND INTERPRETATION
Impact of the emergence of designer drugs upon sports doping testing
20 FEB 2015 CHROMATOGRAPHY
Is there a future for metabotyping in clinical laboratories?
15 MAR 2016 GENERAL INTEREST
Simple, standardized, and sensitive quantification of Bevacizumab (Avastin) using ProteinWorks eXpress Digest Kits
26 JAN 2016 LARGE MOLECULES
Large molecule analysis by LC-MS
6 OCT 2016 NEWS
Researchers use Mass Spec to find new biomarker for pancreatic cancer
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone